DK1275377T3 - Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf - Google Patents

Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf

Info

Publication number
DK1275377T3
DK1275377T3 DK01202657T DK01202657T DK1275377T3 DK 1275377 T3 DK1275377 T3 DK 1275377T3 DK 01202657 T DK01202657 T DK 01202657T DK 01202657 T DK01202657 T DK 01202657T DK 1275377 T3 DK1275377 T3 DK 1275377T3
Authority
DK
Denmark
Prior art keywords
preparation
water
soluble substances
granules containing
containing fat
Prior art date
Application number
DK01202657T
Other languages
English (en)
Inventor
Alberto Reiner
Original Assignee
Applied Pharma Res
Ipsen Spa
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Pharma Res, Ipsen Spa, Fidia Farmaceutici filed Critical Applied Pharma Res
Application granted granted Critical
Publication of DK1275377T3 publication Critical patent/DK1275377T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Edible Oils And Fats (AREA)
DK01202657T 2001-07-11 2001-07-11 Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf DK1275377T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01202657A EP1275377B1 (en) 2001-07-11 2001-07-11 Granulates containing liposoluble substances and process of preparation thereof

Publications (1)

Publication Number Publication Date
DK1275377T3 true DK1275377T3 (da) 2003-10-06

Family

ID=8180628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01202657T DK1275377T3 (da) 2001-07-11 2001-07-11 Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf

Country Status (21)

Country Link
US (1) US7615547B2 (da)
EP (1) EP1275377B1 (da)
JP (1) JP2004536118A (da)
KR (1) KR100877628B1 (da)
AT (1) ATE243028T1 (da)
AU (1) AU2002328866B2 (da)
BR (1) BR0211081A (da)
CA (1) CA2452386C (da)
DE (1) DE60100389T2 (da)
DK (1) DK1275377T3 (da)
ES (1) ES2199202T3 (da)
HR (1) HRP20040010A2 (da)
IL (1) IL159346A0 (da)
MX (1) MXPA04000211A (da)
NO (1) NO20040043L (da)
NZ (1) NZ530473A (da)
PL (1) PL204963B1 (da)
PT (1) PT1275377E (da)
RU (1) RU2288704C2 (da)
WO (1) WO2003005989A2 (da)
ZA (1) ZA200309680B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080486A1 (en) 2000-11-29 2005-04-14 Fallin T. Wade Facet joint replacement
US6579319B2 (en) 2000-11-29 2003-06-17 Medicinelodge, Inc. Facet joint replacement
US7753937B2 (en) 2003-12-10 2010-07-13 Facet Solutions Inc. Linked bilateral spinal facet implants and methods of use
PL1795183T3 (pl) * 2005-12-09 2009-12-31 Teva Pharma Wodne dyspersje i roztwory słabo rozpuszczalnych związków oraz sposoby ich wytwarzania
AU2007339080B2 (en) * 2006-12-22 2012-09-27 Yuhan Corporation Revaprazan-containing solid dispersion and process for the preparation thereof
CN106635949B (zh) * 2011-12-22 2020-05-19 生命技术公司 细胞培养基和方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CA3068088C (en) * 2017-06-23 2024-01-23 Medcan Pharma A/S Cannabinoid pouch
CN108309933A (zh) * 2018-03-19 2018-07-24 青岛国海生物制药有限公司 一种口服醋酸甲地孕酮纳米混悬液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610037A1 (de) * 1986-03-21 1987-09-24 Schering Ag Nifedipinkombinationspraeparat
JPH0449232A (ja) 1990-06-15 1992-02-18 Fujisawa Pharmaceut Co Ltd 懸濁用組成物または懸濁液並びにそれらの製造法
US5338732A (en) 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
EP0721335B1 (en) 1993-10-01 2005-08-31 Roche Palo Alto LLC Mycophenolate mofetil high dose oral suspensions
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
FR2730163B1 (fr) 1995-02-03 1997-04-04 Jouveinal Lab Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation
WO1997033571A1 (fr) 1996-03-14 1997-09-18 Shionogi & Co., Ltd. Preparation d'ecadotril a microdispersion et liberation rapides
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
US6028065A (en) * 1998-04-20 2000-02-22 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
KR20010073232A (ko) 1998-11-20 2001-07-31 추후제출 분산성 인지질로 안정화된 마이크로입자
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form

Also Published As

Publication number Publication date
DE60100389T2 (de) 2004-05-19
KR100877628B1 (ko) 2009-01-07
EP1275377B1 (en) 2003-06-18
HRP20040010A2 (en) 2004-06-30
CA2452386C (en) 2011-01-18
WO2003005989A3 (en) 2003-05-01
BR0211081A (pt) 2004-12-14
PL204963B1 (pl) 2010-02-26
MXPA04000211A (es) 2005-03-07
US20040009232A1 (en) 2004-01-15
AU2002328866B2 (en) 2007-02-15
EP1275377A1 (en) 2003-01-15
JP2004536118A (ja) 2004-12-02
ES2199202T3 (es) 2004-02-16
KR20040018440A (ko) 2004-03-03
PL369294A1 (en) 2005-04-18
PT1275377E (pt) 2003-11-28
WO2003005989A2 (en) 2003-01-23
HRP20040010B1 (da) 2007-01-31
RU2004103853A (ru) 2005-03-27
DE60100389D1 (de) 2003-07-24
NO20040043L (no) 2004-01-06
CA2452386A1 (en) 2003-01-23
IL159346A0 (en) 2004-06-01
US7615547B2 (en) 2009-11-10
NZ530473A (en) 2006-02-24
RU2288704C2 (ru) 2006-12-10
ZA200309680B (en) 2004-12-22
ATE243028T1 (de) 2003-07-15

Similar Documents

Publication Publication Date Title
DK1275377T3 (da) Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf
GT199900069A (es) Preparaciones farmaceuticas estabilizadas de gabapentina y proceso para prepararla.
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
WO2003002136A3 (en) Stable formulation of modified glp-1
ATE395042T1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
WO2002072073A3 (en) Pharmaceutical formulation comprising atorvastatin calcium
FI954905A0 (fi) Kiinteä farmaseuttinen koostumus, joka sisältää täyteainetta, joka kykenee sitomaan vettä
HK1049963A1 (en) Water-containing powder composition, process for producing the same, and cosmetic preparation containing the powder composition.
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
DE3874446T2 (de) Vorrichtung fuer kontrollierte wirkstoffabgabe und zusammensetzungen von partikeln mit solchen vorrichtungen.
ES2190819T3 (es) Procedimiento de preparacion de formulaciones galenicas noveles que contienen fenobrinato, formulaciones galenicas asi obtenidas y sus aplicaciones.
PT1166645E (pt) Amido aglomerado e produto a base de maltodextrina para a preparacao de alimentos
HUP0300334A2 (hu) Gyógyászati készítmények és eljárások azok elżállítására
DE50106179D1 (de) Carotinoidtrockenpulver mit einer Multi-Kern Struktur
EA200600085A1 (ru) Капсулы флуконазола с улучшенным высвобождением
AU2003258720A1 (en) Biocompatible composite capsules
BR0015422A (pt) Formulações de droga de liberação prolongada
WO2002058673A8 (en) Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine
ES2171145A1 (es) Formulacion aceleradora de la descomposicion de materia organica en general y de restos animales en particular; procedimiento para su preparacion y aplicaciones.
DK1263846T3 (da) Dispergerbar og hurtigt hydratiserbar biopolymer
RU2001100615A (ru) Способ применения костного цемента с биологически активными веществами
BR0114734A (pt) 3,4-dihidropirido [1, 2-a] pirimidinas substituìdas
IT1317818B1 (it) Procedimento per la produzione di componenti per integratorialimentari, formulazioni dietetiche, cosmetiche e farmaceutiche,
TW200513273A (en) A long-term effective pharmaceutical preparation containing tamsulosin and preparation thereof
TH59782B (th) สารผสมของกาแลนแทมีนชนิดปลดปล่อยที่มีการควบคุม